Skip to main content
G

Guanhao Biotech Co., Ltd — Investor Relations & Filings

Ticker · 300238 Shenzhen Stock Exchange Manufacturing
Filings indexed 1,710 across all filing types
Latest filing 2026-03-25 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 300238

About Guanhao Biotech Co., Ltd

https://www.guanhaobio.com

Guanhao Biotech Co., Ltd. specializes in the research, development, and commercialization of regenerative medicine and biomaterial-based medical devices. The company focuses on tissue engineering and the production of high-tech implants designed to repair or replace damaged human tissues. Its core product portfolio includes biological patches for neurosurgery, such as dura mater repair patches, as well as solutions for ophthalmology, including corneal repair materials. Utilizing advanced processing technologies for animal-derived materials, the company creates biocompatible scaffolds that facilitate natural tissue regeneration while minimizing immunological rejection. Guanhao Biotech serves clinical needs across various surgical specialties, including orthopedics and wound management, by providing innovative surgical meshes and regenerative matrices. Its commitment to biotechnological innovation supports the advancement of reconstructive surgeries.

Recent filings

Filing Released Lang Actions
内部审计制度(2026年3月)
Regulatory Filings
2026-03-25 Chinese
2025年度内部控制审计报告
Regulatory Filings
2026-03-25 Chinese
董事、高管薪酬管理制度(2026年3月)
Regulatory Filings
2026-03-25 Chinese
独立董事提名人声明与承诺
Regulatory Filings
2026-03-25 Chinese
2025年年度审计报告
Regulatory Filings
2026-03-25 Chinese
关于提请股东会授权董事会办理以简易程序向特定对象发行股票的公告
Regulatory Filings
2026-03-25 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.